A Randomized Double Blind Placebo Controlled Trial of Ramelteon in the Prevention of Post-operative Delirium in Older Patients Undergoing Orthopedic Surgery
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2017
At a glance
- Drugs Ramelteon (Primary) ; Riboflavin
- Indications Delirium
- Focus Therapeutic Use
- Acronyms RECOVER
- 01 Mar 2017 Planned End Date changed from 1 Sep 2020 to 1 Mar 2020.
- 01 Mar 2017 Planned primary completion date changed from 1 Sep 2019 to 1 Mar 2019.
- 01 Mar 2017 Status changed from not yet recruiting to recruiting.